Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
Altered States of Awareness01:06

Altered States of Awareness

147
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
147
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

124
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
124
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Radical Halogenation: Stereochemistry01:33

Radical Halogenation: Stereochemistry

3.7K
Stereochemistry is the study of the different spatial arrangements of atoms in a given molecule. The stereochemistry of radical halogenations can be understood from three different situations:
Halogenation to form a new chiral center:
3.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Ste20 kinase TAOK3 restrains Rac-driven cytoskeletal-mitochondrial coupling to preserve naive CD8<sup>+</sup> T cell homeostasis and activation.

Frontiers in immunology·2026
Same author

Assessing the capability of large language models in answering pediatric critical care board-style questions.

Scientific reports·2026
Same author

<i>Trans</i>-eQTLs reveal the architecture of human gene regulatory networks.

medRxiv : the preprint server for health sciences·2026
Same author

Translation of surface electromyography into a clinically applicable objective bulbar assessment tool to improve measurement-based care in amyotrophic laterals sclerosis.

Frontiers in neuroscience·2026
Same author

<i>The Safer Spaces Project</i>: a whole of community systems approach to co-designing and implementing a 'Safer Spaces' model of primary healthcare for LGBTQ+ young people in Western Victoria - a protocol for a mixed-methods study.

BMJ open·2026
Same author

ALS untangled #83: clenbuterol.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

An open-label Phase 2a study of fasudil in amyotrophic lateral sclerosis: safety and exploratory endpoints.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

Noninvasive assessment of cardiovascular autonomic reflexes in amyotrophic lateral sclerosis: a systematic review.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

The connection between unproven stem cell-based interventions and complementary and alternative medicine in crowdfunding for Amyotrophic Lateral Sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

Thinning of the oral motor cortex is linked to impaired speech in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

Brain activity in an end-stage ALS patient suggests the presence of an unresponsive wakefulness syndrome.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

Whole-body muscle MRI improves diagnostic certainty in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
查看所有相关文章

相关实验视频

Updated: Jun 4, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

8.8K

同样纠的77号:西.

Bhavya Bakshi1, Sandeep Yerraguntla1, Carmel Armon2

  • 1Medical School, Medical College of Georgia at Augusta University, Augusta, GA, USA.

Amyotrophic lateral sclerosis & frontotemporal degeneration
|December 22, 2024
PubMed
概括
此摘要是机器生成的。

迷幻药psilocybin因其神经保护机制而显示出减缓ALS进展的潜力. 然而,目前的研究缺乏,副作用的风险意味着其用于治疗ALS的使用尚未得到支持.

关键词:
这种药物是psilocybin.这是一种炎症炎症炎症炎症.神经发生神经发生.迷幻药物 迷幻药物是一种精神药物.

更多相关视频

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K
Examining Monosynaptic Connections in Drosophila Using Tetrodotoxin Resistant Sodium Channels
09:55

Examining Monosynaptic Connections in Drosophila Using Tetrodotoxin Resistant Sodium Channels

Published on: February 14, 2018

9.9K

相关实验视频

Last Updated: Jun 4, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

8.8K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K
Examining Monosynaptic Connections in Drosophila Using Tetrodotoxin Resistant Sodium Channels
09:55

Examining Monosynaptic Connections in Drosophila Using Tetrodotoxin Resistant Sodium Channels

Published on: February 14, 2018

9.9K

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.
  • 肌缩侧面硬化症 (ALS) 研究研究

背景情况:

  • 患者对替代性和非标签性ALS治疗方法的兴趣正在增长.
  • 来自的迷幻化合物psilocybin正在探索其治疗潜力.

研究的目的:

  • 审查psilocybin作为一种疾病修饰疗法的潜力,用于肌缩侧面硬化症 (ALS).
  • 评估当前的证据和与ALS相关的西宾使用相关的风险.

主要方法:

  • 对西的特性和对神经发生和炎症的潜在影响的文献综述.
  • 评估现有的临床前模型,病例报告和与西和ALS相关的临床试验.

主要成果:

  • 西可以穿越血脑屏障,并且具有影响神经发生和炎症的可信机制.
  • 目前没有临床前ALS模型,病例报告或试验评估psilocybin对ALS疾病的修饰.
  • 存在很高的心理副作用 (幻觉) 和身体伤害的风险,取决于剂量.

结论:

  • 目前,由于证据不足和潜在风险,psilocybin的使用并不被支持作为减缓ALS进展的手段.
  • 需要进一步的研究来确定西在ALS治疗中的安全性和有效性.